Reorganization plan of KFDA gets mixed responses

Published: 2013-01-30 06:57:00

Updated: 2013-01-30 06:57:00

The new Cheong Wa Dae under President-elect Park Geun-hye aims to become smaller and more efficient with the staff’s roles realigned and integrated. But many of the new posts have the risk of overlapping in their roles, leaving a large proportion of the functions to be sorted out.

The Korea Fo...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK